摘要
目的和方法研究肝双重血管灌注化疗治疗不能切除的中晚期肝癌，本研究将６７例不能切除的肝癌分为两组，Ａ组３５例经肝动脉置泵化疗，Ｂ组３２例经肝动脉、门静脉置泵化疗。结果对照分析发现：Ａ组中位生存期８个月，一年生存率２５７％，５例新出现门静脉癌栓；Ｂ组明显优于Ａ组，其中位生存期１１个月，一年生存率４２９％，无新生门静脉癌栓。
Aim:To stady chemotherapy in the double-vessels of liver in the middle or late hepatic carcinoma. Method:In the cases who had not chance to be operated into two groupes.In group A 35 cases were placed chemotherapy pumps in hepatic arteries.In group B 32 cases were placed chemotherapy pumps in hepatic arteres and portal veins.Result:By contrast we include that:In group A the average survival date is 8 monthes,one year survial rate is 25.7%.In 5 cases new carcinoma thrombi were discovered in portal veins.The effcet of group B in suprior to that of group B.In group B the average survival date is 11 monthes,one year survival rate is 42.9%.No thrombi were discovered in portal veins.Conclusion:the infusion chemotherapy in the double vessels of liver is a benificial treament way in the middle or late hepatic carcinoma.
出处
《胃肠病学和肝病学杂志》
CAS
1997年第3期256-257,共2页
Chinese Journal of Gastroenterology and Hepatology
关键词
肝肿瘤
血管灌注
化学疗法
Heptic artery and portal vein Chemotherapy Hepatic carcioma
